Abstract

Recent advances in biology hold out the real possibility of significant progress in the treatment of disease. At the same time however these technological discoveries have posed serious challenges to policy makers, the decision by the UK Court of Appeal in Zain Hashmi being a case in point. Judges and legislators have traditionally tried to apply principles of justice in the matters that lie before them. Future issues that involve genetic technology have the potential to involve more than this since they imply an imperative to redefine ethical perimeters. However the new genetics goes beyond this and necessitates redefining human perimeters as well. This paper considers a position broadly known as consequentialism – in which outcomes are to be as good as possible - and argues instead on behalf of an approach to bioethical issues which demands consideration of the fairness of the procedures employed